🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Arash Hatefi

Rutgers, The State University of New Jersey

ORCID: 0000-0003-4611-7469
Biochemistry, Genetics and Molecular BiologyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice”.

Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008295
N/A
0.470DataRank · unranked
22 citations

Ge Yang, Hajar Owji, Mayara Grizotte-Lake, Rick I. Cohen, Lázaro Gil +3 more

Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands

Medical Oncology(2023)10.1007/s12032-023-01975-1
N/A
0.312DataRank · unranked
7 citations

Shahryar Khoshtinat Nikkhoi, Arash Hatefi, Geng Li

Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy

Frontiers in Immunology(2023)10.3389/fimmu.2022.1039969
N/A
0DataRank · unranked
47 citations

Geng Li, Suha Eleya, Ge Yang, Venu Gopal Vandavasi, Arash Hatefi +1 more

A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab’s epitope with versatile biochemical, biological, and medical applications

Immunologic Research(2023)10.1007/s12026-023-09418-9
N/A
0DataRank · unranked
10 citations

Hediyeh Heydarzadeh, Venu Gopal Vandavasi, Ge Yang, Pedro Louro, Marianne Polunas +3 more

A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumors

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.03.019
N/A
0DataRank · unranked
30 citations

Siavash Yousefi, Davit Sargsyan, Arash Hatefi, Alireza Nomani

A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide

Antibodies(2024)10.3390/antib13030075
N/A
0DataRank · unranked
2 citations

Shahryar Khoshtinat Nikkhoi, Hajar Owji, Geng Li, Mohammad Massumi, Jessica A. Cervelli +3 more

Natural killer cell engagers for cancer immunotherapy

Frontiers in Oncology(2025)10.3389/fonc.2024.1483884
N/A
0DataRank · unranked
18 citations

Geng Li, Arash Hatefi, Shahryar Khoshtinat Nikkhoi

Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI

Journal of Controlled Release(2021)10.1016/j.jconrel.2021.07.022
N/A
0DataRank · unranked
15 citations

Geng Li, Siavash Yousefi, Shawn Wu, Obeid M. Malekshah, Shahryar Khoshtinat Nikkhoi +4 more

Engineered tumor-tropic mesenchymal stem cells as targeted therapeutic delivery systems for refractory Ovarian cancer

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.114584
N/A
0DataRank · unranked
2 citations

Mohammad Massumi, Hajar Owji, Ge Yang, Eugenia Girda, Arash Hatefi +1 more

Incorporation of histone derived recombinant protein for enhanced disassembly of core-membrane structured liposomal nanoparticles for efficient siRNA delivery

UNC Libraries(2021)10.17615/fy72-6z03
N/A
0DataRank · unranked
2 citations

Lu Zhang, Leaf Huang, Shutao Guo, Arash Hatefi, Yuhua Wang